Pitfall of 18F-PSMA PyL PET/CT Imaging of a Displaced Urinary Bladder as Recurrent Prostate Malignancy

被引:0
|
作者
Tewari, Sanjit O. [1 ]
Metwalli, Zeyad A. [2 ]
Xu, Guofan [1 ,3 ]
机构
[1] Univ Texas MD Anderson Canc Ctr, Dept Nucl Med, Div Diagnost Imaging, Houston, TX USA
[2] Univ Texas MD Anderson Canc Ctr, Dept Intervent Radiol, Div Diagnost Imaging, Houston, TX USA
[3] Univ Texas MD Anderson Canc Ctr, Dept Nucl Med, Div Diagnost Imaging, Unit Number 1483,1400 Pressler St, Houston, TX 77030 USA
关键词
PSMA; PSMA PET; lymphocele;
D O I
10.1097/RLU.0000000000004876
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
We herein present a potential pitfall in the setting of restaging PSMA PyL PET/CT. In this case, there is large non-PSMA-avid cystic structure in the mid pelvis, probably representing a postprostatectomy lymphocele, which was mistaken for the urinary bladder, resulting in the displaced and somewhat crescentic urinary bladder to be deemed recurrence. Subsequently, biopsy and retrospective review of images confirms displaced urinary bladder containing physiologic excreted activity.
引用
收藏
页码:1071 / 1072
页数:2
相关论文
共 50 条
  • [41] More advantages in detecting bone and soft tissue metastases from prostate cancer using 18F-PSMA PET/CT
    Pianou, Nikoletta K.
    Stavrou, Petros Z.
    Vlontzou, Evangelia
    Rondogianni, Phivi
    Exarhos, Demetrios N.
    Datseris, Ioannis E.
    HELLENIC JOURNAL OF NUCLEAR MEDICINE, 2019, 22 (01): : 6 - 9
  • [42] Case Report: 18F-PSMA PET/CT May Improve the Clinical Management of Penile Metastases From Prostate Cancer
    Fan, Junjie
    Liang, Hua
    Zhang, Xing
    Chen, Xingfa
    Duan, Xiaoyi
    Li, Lei
    He, Dalin
    Wu, Kaijie
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [43] 18F-fluciclovine PET or PSMA PET for prostate cancer imaging?
    Baris Turkbey
    Peter L. Choyke
    Nature Reviews Urology, 2020, 17 : 9 - 10
  • [44] The Canadian PET Phantom for Prostate Oncology (C3PO) - A Multimodality Imaging Phantom for 18F-PSMA Harmonization
    Fedrigo, R.
    Coope, R.
    Rahmim, A.
    Benard, F.
    Uribe, C.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 48 (SUPPL 1) : S255 - S256
  • [45] Development of the quantitative PET prostate phantom (Q3P) for improved quality assurance of 18F-PSMA PET imaging in metastatic prostate cancer
    Fedrigo, Roberto
    Coope, Robin
    Rahmim, Arman
    Benard, Francois
    Uribe, Carlos F.
    MEDICAL PHYSICS, 2024, 51 (06) : 4311 - 4323
  • [46] PROSTATE CANCER 18F-fluciclovine PET or PSMA PET for prostate cancer imaging?
    Turkbey, Baris
    Choyke, Peter L.
    NATURE REVIEWS UROLOGY, 2020, 17 (01) : 9 - 10
  • [47] miPSMA Index: Comprehensive and Automated Quantification of 18F-DCFPyL (PyL-PSMA) PET/CT for Prostate Cancer Staging
    Johnsson, Kerstin
    Sahlstedt, Hannicka
    Brynolfsson, Johan
    Dang, Johnny
    Ceccoli, John
    Lin, Tess
    Richter, Jens
    Sjostrand, Karl
    Edenbrandt, Lars
    Eiber, Matthias
    Anand, Aseem
    JOURNAL OF NUCLEAR MEDICINE, 2020, 61
  • [48] The Diagnostic Role of 18F-Choline, 18F-Fluciclovine and 18F-PSMA PET/CT in the Detection of Prostate Cancer With Biochemical Recurrence: A Meta-Analysis
    Wang, Rang
    Shen, Guohua
    Huang, Mingxing
    Tian, Rong
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [49] Comparison of 68Ga-PSMA-11 PET/CT and 18F-Fluciclovine PET/CT in recurrent Prostate Cancer
    Ceci, F.
    Polverari, G.
    Gartmann, J.
    Fendler, W.
    Eiber, M.
    Herrmann, K.
    Czernin, J.
    Calais, J.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 : S150 - S150
  • [50] 18F-PSMA PET/CT is Helpful in the Evaluation of Intermediate Risk Favorable and Low Risk Prostate Cancer Patients: A Pictorial Essay
    Green, Aileen
    Temsah, Peter
    Alsagheer, Atheel
    Abdalla, Ahmed
    Gu, Lin
    Muzaffar, Razi
    Osman, Medhat
    JOURNAL OF NUCLEAR MEDICINE, 2023, 64